Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of infectious diseases globally
3.2.1.2 Increasing adoption of personalized medicine
3.2.1.3 Growing demand for point of care testing
3.2.1.4 Rising R&D investments for developing novel biotechnological diagnostic techniques
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of instruments and reagents
3.2.2.2 Stringent regulatory scenario
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Porter’s analysis
3.6.1 Supplier power
3.6.2 Buyer power
3.6.3 Threat of new entrants
3.6.4 Threat of substitutes
3.6.5 Industry rivalry
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Product Type, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Consumables
5.3 Instruments/Systems
Chapter 6 Market Estimates and Forecast, By Technology, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Polymerase chain reaction (PCR) tests
6.3 Isothermal nucleic acid amplification technology (INAAT) tests
6.4 Ligase chain reaction (LCR) tests
Chapter 7 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Infectious disease testing
7.2.1 COVID-19 testing
7.2.2 Mosquito borne disease testing
7.2.3 Influenza testing
7.2.4 Sexually transmitted infections testing
7.2.5 Hepatitis testing
7.2.6 Tuberculosis testing
7.2.7 Other infectious disease testing
7.3 Oncology testing
7.4 Genetic & mitochondrial disease testing
7.5 Other applications
Chapter 8 Market Estimates and Forecast, By End-Use, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals
8.3 Diagnostic laboratories
8.4 Biotechnology companies
8.5 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 Saudi Arabia
9.6.2 South Africa
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Abbott Laboratories
10.2 Becton, Dickinson and Company
10.3 bioMerieux S.A.
10.4 Bio-Rad Laboratories, Inc.
10.5 Danaher Corporation
10.6 F. Hoffmann La Roche AG
10.7 Illumina, Inc.
10.8 QIAGEN N.V.
10.9 Seegene Inc.
10.10 Siemens Healthineers AG
